ORIC Pharmaceuticals, Inc. (ORIC)
NASDAQ: ORIC · Real-Time Price · USD
13.71
-0.14 (-1.01%)
At close: Mar 6, 2026, 4:00 PM EST
13.51
-0.20 (-1.46%)
After-hours: Mar 6, 2026, 7:56 PM EST
ORIC Pharmaceuticals Market Cap
ORIC Pharmaceuticals has a market cap or net worth of $1.38 billion as of March 6, 2026. Its market cap has increased by 159.33% in one year.
Market Cap
1.38B
Enterprise Value
1.10B
1-Year Change
159.33%
Ranking
Category
Stock Price
$13.71
Market Cap Chart
Since April 24, 2020, ORIC Pharmaceuticals's market cap has increased from $741.98M to $1.38B, an increase of 85.44%. That is a compound annual growth rate of 11.10%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 1.38B | 72.71% |
| Dec 31, 2025 | 796.64M | 39.89% |
| Dec 31, 2024 | 569.48M | 13.47% |
| Dec 29, 2023 | 501.88M | 89.55% |
| Dec 30, 2022 | 264.77M | -54.26% |
| Dec 31, 2021 | 578.91M | -53.32% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Apr 24, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| MBX Biosciences | 1.48B |
| Vir Biotechnology | 1.45B |
| Monte Rosa Therapeutics | 1.42B |
| Rapport Therapeutics | 1.41B |
| Immatics | 1.36B |
| Savara | 1.36B |
| Zenas BioPharma | 1.36B |
| Corvus Pharmaceuticals | 1.35B |